Nociceptive sensitization by endothelin-1

Brain Research Reviews

Volumn 60, Issue 1, 2009, Pages 36-42

  Hans, Guy ^a   Schmidt, Brian L ^b   Strichartz, Gary ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Endothelin; Inflammation; Neuropathy; Pain; Sensitization

Indexed keywords

ATRASENTAN; CALCIUM CHANNEL BLOCKING AGENT; CARBOPLATIN; CARRAGEENAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; MORPHINE; PACLITAXEL; PROOPIOMELANOCORTIN; VANILLOID RECEPTOR 1;

ALLODYNIA; ANALGESIA; BRONCHUS MUCOSA; CANCER PAIN; CHEMOTAXIS; DOPAMINE RELEASE; HUMAN; HYPERALGESIA; INFLAMMATION; INTRACELLULAR TRANSPORT; KERATINOCYTE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MORPHINE TOLERANCE; MOUSE; NEUROBLASTOMA CELL; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HUMANS; INFLAMMATION MEDIATORS; NEOPLASMS; NOCICEPTORS; PAIN; RECEPTORS, ENDOTHELIN; RECEPTORS, G-PROTEIN-COUPLED; SENSORY RECEPTOR CELLS;

EID: 63449139697     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.12.008     Document Type: Review

References (73)

1. Achmad T.H., and Rao G.S. Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem. Biophys. Res. Commun. 189 (1992) 994-1000
2. Ahmed S.I., Thompson J., Coulson J.M., and Woll P.J. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 22 (2000) 422-431
3. Baamonde A., Lastra A., Villazon M., Bordallo J., Hidalgo A., and Menendez L. Involvement of endogenous endothelins in thermal and mechanical inflammatory hyperalgesia in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 369 (2004) 245-251
4. Bagnato A., and Rosano L. The endothelin axis in cancer. Int. J. Biochem. Cell Biol. 40 (2008) 1443-1451
5. Balonov K., Khodorova A., and Strichartz G.R. Tactile allodynia initiated by local subcutaneous endothelin-1 is prolonged by activation of TRPV-1 receptors. Exp. Biol. Med. (Maywood) 231 (2006) 1165-1170
6. Bertelli A., Clerico A., Chicca A., Giovannini L., Gorio A., and Romano M.A. Role of endothelin-1 in carrageenin-induced inflammation. Int. J. Tissue React. 14 (1992) 225-230
7. Berti-Mattera L.N., Gariepy C.E., Burke R.M., and Hall A.K. Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes. Exp. Neurol. 201 (2006) 399-406
8. Bhalla S., Matwyshyn G., and Gulati A. Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats. Peptides 24 (2003) 553-561
9. Bhalla S., Matwyshyn G., and Gulati A. Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists. Brain Res. 1064 (2005) 126-135
10. Bhalla S., Ciaccio N., Wang Z.J., and Gulati A. Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells. Exp. Biol. Med. (Maywood) 231 (2006) 1152-1156
11. Boyle Jr. E.M., Lille S.T., Allaire E., Clowes A.W., and Verrier E.D. Endothelial cell injury in cardiovascular surgery: atherosclerosis. Ann. Thorac. Surg. 63 (1997) 885-894
12. Bremnes T., Paasche J.D., Mehlum A., Sandberg C., Bremnes B., and Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 275 (2000) 17596-17604
13. Cain D.M., Wacnik P.W., Turner M., Wendelschafer-Crabb G., Kennedy W.R., Wilcox G.L., and Simone D.A. Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J. Neurosci. 21 (2001) 9367-9376
14. Chiappori A.A., Haura E., Rodriguez F.A., Boulware D., Kapoor R., Neuger A.M., Lush R., Padilla B., Burton M., Williams C., Simon G., Antonia S., Sullivan D.M., and Bepler G. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer. Clin. Cancer Res. 14 (2008) 1464-1469
15. Chichorro J.G., Zampronio A.R., and Rae G.A. Endothelin ET(B) receptor antagonist reduces mechanical allodynia in rats with trigeminal neuropathic pain. Exp. Biol. Med. (Maywood) 231 (2006) 1136-1140
16. Chichorro J.G., Zampronio A.R., Souza G.E., and Rae G.A. Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs. Pain 123 (2006) 64-74
17. Cho H., Lee D., Lee S.H., and Ho W.K. Receptor-induced depletion of phosphatidylinositol 4, 5-bisphosphate inhibits inwardly rectifying K+ channels in a receptor-specific manner. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4643-4648
18. Connelly S.T., and Schmidt B.L. Evaluation of pain in patients with oral squamous cell carcinoma. J. Pain 5 (2004) 505-510
19. Cui P., Tani K., Kitamura H., Okumura Y., Yano M., Inui D., Tamaki T., Sone S., and Kido H. A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J. Leukoc. Biol. 70 (2001) 306-312
20. Davar G., Hans G., Fareed M.U., Sinnott C., and Strichartz G. Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport. 9 (1998) 2279-2283
21. De-Melo J.D., Tonussi C.R., D'Orleans-Juste P., and Rae G.A. Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists. Pain 77 (1998) 261-269
22. Ehrenreich H., Anderson R.W., Fox C.H., Rieckmann P., Hoffman G.S., Travis W.D., Coligan J.E., Kehrl J.H., and Fauci A.S. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 172 (1990) 1741-1748
23. Elferink J.G., and de Koster B.M. Endothelin-induced activation of neutrophil migration. Biochem. Pharmacol. 48 (1994) 865-871
24. Fujita M., Andoh T., Saiki I., and Kuraishi Y. Involvement of endothelin and ET(A) endothelin receptor in mechanical allodynia in mice given orthotopic melanoma inoculation. J. Pharmacol. Sci. 106 (2008) 257-263
25. Gandhi C.R., Berkowitz D.E., and Watkins W.D. Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology 80 (1994) 892-905
26. Gokin A.P., Pan H., Sinnott C., Strichartz G., and Davar G. Selective, endothelin-A receptor-dependent, excitation of nociceptive sensory fibers by endothelin-1 applied to the rat plantar hindpaw. Soc. Neurosci. Abstr. 634.4 (2000) 1694
27. Gokin A.P., Fareed. M.U., Pan H.L., Hans G., Strichartz G.R., and Davar G. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J. Neurosci. 21 (2001) 5358-5366
28. Griswold D.E., Douglas S.A., Martin L.D., Davis T.G., Davis L., Ao Z., Luttmann M.A., Pullen M., Nambi P., Hay D.W., and Ohlstein E.H. Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol. Pharmacol. 56 (1999) 807-812
29. Haberberger R.V., and Bodenbenner M. Immunohistochemical localization of muscarinic receptors (M2) in the rat skin. Cell Tissue Res. 300 (2000) 389-396
30. Hasue F., Kuwaki T., Kisanuki Y.Y., Yanagisawa M., Moriya H., Fukuda Y., and Shimoyama M. Increased sensitivity to acute and persistent pain in neuron-specific endothelin-1 knockout mice. Neuroscience 130 (2005) 349-358
31. Held B., Pocock J.M., and Pearson H.A. Endothelin-1 inhibits voltage-sensitive Ca2+ channels in cultured rat cerebellar granule neurones via the ET-A receptor. Pflugers Arch. 436 (1998) 766-775
32. Houck C.S., Khodorova A., Reale A.M., Strichartz G.R., and Davar G. Sensory fibers resistant to the actions of tetrodotoxin mediate nocifensive responses to local administration of endothelin-1 in rats. Pain 110 (2004) 719-726
33. Inagaki H., Bishop A.E., Eimoto T., and Polak J.M. Autoradiographic localization of endothelin-1 binding sites in human colonic cancer tissue. J. Pathol. 168 (1992) 263-267
34. Jarvis M.F., Wessale J.L., Zhu C.Z., Lynch J.J., Dayton B.D., Calzadilla S.V., Padley R.J., Opgenorth T.J., and Kowaluk E.A. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur. J. Pharmacol. 388 (2000) 29-35
35. Kar S., Yousem S.A., and Carr B.I. Endothelin-1 expression by human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 216 (1995) 514-519
36. Khodorova A., Fareed M.U., Gokin A., Strichartz G.R., and Davar G. Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner. J. Neurosci. 22 (2002) 7788-7796
37. Khodorova A., Navarro B., Jouaville L.S., Murphy J.E., Rice F.L., Mazurkiewicz J.E., Long-Woodward D., Stoffel M., Strichartz G.R., Yukhananov R., and Davar G. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med. 9 (2003) 1055-1061
38. Khodorova A., Vasko M.R., Ritcher J.A., and Strichartz G. NMDA receptors favor tactile allodynia induced by injection of low concentrations of endothelin-1 into the rat's hindpaw. Soc. for Neurosci. Ann. Mtg. Abstracts 245 (2006) 23
39. Klass M., Hord A., Wilcox M., Denson D., and Csete M. A role for endothelin in neuropathic pain after chronic constriction injury of the sciatic nerve. Anesth. Analg. 101 (2005) 1757-1762
40. Kolokythas A., Connelly S.T., and Schmidt B.L. Validation of the University of California San Francisco oral cancer pain questionnaire. J. Pain 8 (2007) 950-953
41. Lewin G.R., and Mendell L.M. Nerve growth factor and nociception. Trends Neurosci. 16 (1993) 353-359
42. Menendez L., Lastra A., Hidalgo A., and Baamonde A. Nociceptive reaction and thermal hyperalgesia induced by local ET-1 in mice: a behavioral and Fos study. Naunyn Schmiedebergs Arch. Pharmacol. 367 (2003) 28-34
43. Miyasaka N., Hirata Y., Ando K., Sato K., Morita H., Shichiri M., Kanno K., Tomita K., and Marumo F. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum. 35 (1992) 397-400
44. Morita T., Ando M., Kihara K., Matsumura T., Kamai T., Oshima H., Tsuchiya N., and Kondo S. Effects of endothelin-1 on the smooth muscle contractility of human urinary bladder, spermatic cord and prostatic adenoma. Nippon Hinyokika Gakkai Zasshi 84 (1993) 1649-1654
45. Nelson J.B., Hedican S.P., George D.J., Reddi A.H., Piantadosi S., Eisenberger M.A., and Simons J.W. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. 1 (1995) 944-949
46. Ohnaka K., Oike M., Takayangi R., Yanase T., Haji M., and Nawata H. The role of endothelin in adrenal medulla: identification of endothelin and its receptor in two cases of pheochromocytoma. Fukuoka Igaku Zasshi 84 (1993) 97-99
47. Oikawa T., Kushuhara M., Ishikawa S., Hitomi J., Kono A., Iwanaga T., and Yamaguchi K. Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells. Br. J. Cancer. 69 (1994) 1059-1064
48. Pekonen F., Saijonmaa O., Nyman T., and Fyhrquist F. Human endometrial adenocarcinoma cells express endothelin-1. Mol. Cell. Endocrinol. 84 (1992) 203-207
49. Peters C.M., Lindsay T.H., Pomonis J.D., Luger N.M., Ghilardi J.R., Sevcik M.A., and Mantyh P.W. Endothelin and the tumorigenic component of bone cancer pain. Neuroscience 126 (2004) 1043-1052
50. Pickering V., Jordan R.C., and Schmidt B.L. Elevated salivary endothelin levels in oral cancer patients-a pilot study. Oral Oncol. 43 (2007) 37-41
51. Pickering V., Jay Gupta R., Quang P., Jordan R.C., and Schmidt B.L. Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice. Eur. J. Pain 12 (2008) 293-300
52. Piovezan A.P., D'Orleans-Juste P., Tonussi C.R., and Rae G.A. Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur. J. Pharmacol. 351 (1998) 15-22
53. Piovezan A.P., D'Orleans-Juste P., Souza G.E., and Rae G.A. Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation. Br. J. Pharmacol. 129 (2000) 961-968
54. Plant T.D., Zollner C., Kepura F., Mousa S.S., Eichhorst J., Schaefer M., Furkert J., Stein C., and Oksche A. Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol. Pain. 3 (2007) 35
55. Pomonis J.D., Rogers S.D., Peters C.M., Ghilardi J.R., and Mantyh P.W. Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J. Neurosci. 21 (2001) 999-1006
56. Puppala B.L., Matwyshyn G., Bhalla S., and Gulati A. Role of endothelin in neonatal morphine tolerance. J. Cardiovasc. Pharmacol. 44 (2004) S383-S385
57. Raffa R.B., Schupsky J.J., and Jacoby H.I. Endothelin-induced nociception in mice: mediation by ETA and ETB receptors. J. Pharmacol. Exp. Ther. 276 (1996) 647-651
58. Rubanyi G.M., and Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46 (1994) 325-415
59. Schmidt B.L., Pickering V., Liu S., Quang P., Dolan J., Connelly S.T., and Jordan R.C. Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain. Eur. J. Pain 11 (2007) 406-414
60. Sessa W.C., Kaw S., Hecker M., and Vane J.R. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 174 (1991) 613-618
61. Shankar A., Loizidou M., Aliev G., Fredericks S., Holt D., Boulos P.B., Burnstock G., and Taylor I. Raised endothelin 1 levels in patients with colorectal liver metastases. Br. J. Surg. 85 (1998) 502-506
62. van den Buuse M., and Webber K.M. Endothelin and dopamine release. Prog. Neurobiol. 60 (2000) 385-405
63. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., and Wilcox G.L. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J. Neurosci. 21 (2001) 9355-9366
64. Webb D.J. Endothelin: from molecule to man. Br. J. Clin. Pharmacol. 44 (1997) 9-20
65. Wintzen M., Yaar M., Burbach J.P., and Gilchrest B.A. Proopiomelanocortin gene product regulation in keratinocytes. J. Invest. Dermatol. 106 (1996) 673-678
66. Wintzen M., Zanello S.B., Holick M.F., Wiegant V.M., Burbach J.P., and Vermeer B.J. Condition-dependent presence of beta-lipotropin-like peptide in human keratinocytes. Peptides 21 (2000) 691-697
67. Yamamoto T., Shimoyama N., Asano H., and Mizuguchi T. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist. J. Pharmacol. Exp. Ther. 271 (1994) 156-163
68. Yamashita J., Ogawa M., Nomura K., Matsuo S., Inada K., Yamashita S., Nakashima Y., Saishoji T., Takano S., and Fujita S. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res. 53 (1993) 464-467
69. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
70. Yoshizumi M., Kurihara H., Morita T., Yamashita T., Oh-hashi Y., Sugiyama T., Takaku F., Yanagisawa M., Masaki T., and Yazaki Y. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem. Biophys. Res. Commun. 166 (1990) 324-329
71. Yuyama H., Koakutsu A., Fujiyasu N., Fujimori A., Sato S., Shibasaki K., Tanaka S., Sudoh K., Sasamata M., and Miyata K. Inhibitory effects of a selective endothelin-a receptor antagonist YM598 on endothelin-1-induced potentiation of nociception in formalin-induced and prostate cancer-induced pain models in mice. J. Cardiovasc. Pharmacol. 44 Suppl. 1 (2004) S479-S482
72. Zanello S.B., Jackson D.M., and Holick M.F. An immunocytochemical approach to the study of beta-endorphin production in human keratinocytes using confocal microscopy. Ann. N.Y. Acad. Sci. 885 (1999) 85-99
73. Zhou Z., Davar G., and Strichartz G. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J. Neurosci. 22 (2002) 6325-6330